- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeroen Jansen Outlines Challenges With Incorporating Novel Elements in Value Assessment
Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Transcript
What challenges are there with incorporating more novel concepts of value into value assessment?
That’s an interesting question. Traditionally, a lot of the value assessment is done in what’s called a cost-effectiveness analysis framework where we calculate the expected costs and the expected risks and benefits for the patients. But now, there’s a discussion like what novel elements need to be incorporated. For example, one of the novel elements is what’s called “value of hope,” which means that even if on the average, 2 interventions give you the same benefits, it might be that one of the interventions has more variation in how individual patients may respond versus the other intervention. It might be that certain patients prefer the intervention where you see more variation in response because they might be the lucky ones to respond much better than the simple average. That’s currently, for example, overlooked.
Another component, one of the other novel elements, is something that’s called insurance value, where we say currently, value assessment is all about how can we optimize treatment allocation given the budgets we have to work with. But, the value of an intervention goes beyond the individuals patients. For example, if we have a new efficacious treatment for example for Alzheimer, that benefits everyone of us that is potentially at risk for Alzheimer disease.
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More
Kathy Oubre on Strategies to Mitigate Challenges When Adopting New Payment Models
February 23rd 2024While adopting new payment models can come with challenges, there are strategies that can help oncology practices optimize their approaches, said Kathy Oubre, MS, CEO of Pontchartrain Cancer Center.
Read More
